enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. UPDATE 1-Former head of Australia's Sirtex pleads guilty to ...

    www.aol.com/news/1-former-head-australias-sirtex...

    The former head of Australian liver-cancer treatment firm Sirtex Medical Ltd has pleaded guilty to insider trading, Australia's corporate regulator said on Wednesday. Gilman Edwin Wong, who headed ...

  3. Australia's Sirtex expects approval for Chinese buyout - AOL

    www.aol.com/news/australias-sirtex-expects...

    Australian liver cancer treatment maker Sirtex Medical Ltd expects its $1.4 billion buyout by a Chinese consortium to will win regulatory approval in Australia and the United States despite ...

  4. Sirtex - Wikipedia

    en.wikipedia.org/wiki/Sirtex

    Sirtex Medical Limited is a medical device firm that offers radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. [1] Sirtex was founded in 1997 in Australia and today has offices and production facilities in the U.S. , Australia , Germany , and Singapore .

  5. Varian Medical Receives Regulatory Nod for Sirtex Buyout - AOL

    www.aol.com/news/varian-medical-receives...

    The acquisition of Sirtex will fortify Varian Medical's (VAR) footprint in Australia. The transaction is likely to close in late May 2018. ... News. 24/7 help. For premium support please call: 800 ...

  6. Medical News Network - Wikipedia

    en.wikipedia.org/wiki/Medical_News_Network

    Programming could be viewed on demand, and included a daily 10-minute news program. The system was interactive, using what Medical Market and Media described as "computer and modem units." [3] The service had been tested in 5,000 doctors' offices, and Whittle had planned to do a national rollout in fall 1994. [4]

  7. Abbrev. [1]Meaning [1] Latin (or Neo-Latin) origin [1]; a.c. before meals: ante cibum a.d., ad, AD right ear auris dextra a.m., am, AM morning: ante meridiem: nocte ...

  8. Sirtex Medical: Interim report - half-year ended 31 ... - AOL

    www.aol.com/news/2013-02-14-sirtex-medical...

    Sirtex Medical: Interim report - half-year ended 31 December 2012 Net profit after tax (NPAT) increased 27.6 per cent to $7.8 million Global dose sales growth of 30.5 per cent Total revenue ...

  9. Sirtex Completes Patient Recruitment for SIRFLOX Study ... - AOL

    www.aol.com/news/2013-04-13-sirtex-completes...

    For premium support please call: 800-290-4726 more ways to reach us